Co-Diagnostics Inc
NASDAQ:CODX
Income Statement
Earnings Waterfall
Co-Diagnostics Inc
Revenue
|
6.8m
USD
|
Cost of Revenue
|
-4.2m
USD
|
Gross Profit
|
2.6m
USD
|
Operating Expenses
|
-45.3m
USD
|
Operating Income
|
-42.7m
USD
|
Other Expenses
|
7.4m
USD
|
Net Income
|
-35.3m
USD
|
Income Statement
Co-Diagnostics Inc
Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+100%
|
0
+50%
|
0
+33%
|
0
-25%
|
0
+167%
|
0
+38%
|
0
+91%
|
2
+738%
|
26
+1 363%
|
48
+85%
|
75
+57%
|
93
+25%
|
96
+4%
|
105
+9%
|
98
-6%
|
101
+3%
|
78
-22%
|
53
-32%
|
34
-36%
|
12
-65%
|
7
-40%
|
5
-36%
|
7
+46%
|
|
Gross Profit | |||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(7)
|
(12)
|
(17)
|
(19)
|
(16)
|
(13)
|
(12)
|
(12)
|
(10)
|
(7)
|
(5)
|
(3)
|
(2)
|
(2)
|
(4)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+100%
|
0
+50%
|
0
N/A
|
0
-33%
|
0
+50%
|
0
+33%
|
0
+150%
|
1
+1 070%
|
19
+1 542%
|
35
+83%
|
58
+65%
|
74
+27%
|
80
+9%
|
91
+13%
|
86
-5%
|
89
+3%
|
68
-23%
|
46
-33%
|
29
-37%
|
9
-67%
|
5
-46%
|
3
-42%
|
3
-10%
|
|
Operating Income | |||||||||||||||||||||||||||||||
Operating Expenses |
(2)
|
(2)
|
(2)
|
(2)
|
(4)
|
(5)
|
(7)
|
(8)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(9)
|
(11)
|
(16)
|
(21)
|
(30)
|
(39)
|
(40)
|
(43)
|
(39)
|
(36)
|
(40)
|
(41)
|
(44)
|
(45)
|
(45)
|
|
Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(7)
|
(9)
|
(13)
|
(15)
|
(21)
|
(25)
|
(25)
|
(26)
|
(22)
|
(20)
|
(22)
|
(21)
|
(22)
|
(22)
|
(21)
|
|
Research & Development |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(5)
|
(9)
|
(14)
|
(15)
|
(17)
|
(16)
|
(15)
|
(17)
|
(19)
|
(21)
|
(22)
|
(23)
|
|
Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(2)
N/A
|
(2)
N/A
|
(2)
-5%
|
(2)
-17%
|
(4)
-68%
|
(5)
-30%
|
(7)
-61%
|
(8)
-9%
|
(6)
+28%
|
(6)
-6%
|
(6)
+1%
|
(6)
0%
|
(6)
+0%
|
(6)
+3%
|
(6)
+3%
|
10
N/A
|
24
+132%
|
42
+73%
|
53
+27%
|
50
-5%
|
52
+3%
|
46
-11%
|
46
-1%
|
30
-35%
|
9
-68%
|
(12)
N/A
|
(31)
-171%
|
(39)
-25%
|
(42)
-6%
|
(43)
-3%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
1
|
1
|
0
|
0
|
(1)
|
(0)
|
0
|
(0)
|
0
|
0
|
1
|
2
|
2
|
4
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
3
|
4
|
7
|
(7)
|
(10)
|
(10)
|
(13)
|
1
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
|
Pre-Tax Income |
(2)
N/A
|
(2)
-3%
|
(2)
-10%
|
(3)
-20%
|
(6)
-135%
|
(7)
-16%
|
(8)
-9%
|
(8)
-7%
|
(6)
+28%
|
(6)
-8%
|
(6)
-1%
|
(6)
+0%
|
(6)
-2%
|
(6)
+3%
|
(6)
+5%
|
10
N/A
|
25
+139%
|
43
+70%
|
54
+26%
|
50
-6%
|
51
+2%
|
46
-11%
|
49
+7%
|
33
-31%
|
16
-51%
|
(19)
N/A
|
(40)
-112%
|
(48)
-19%
|
(52)
-10%
|
(38)
+27%
|
|
Net Income | |||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
(0)
|
(2)
|
(4)
|
(9)
|
(9)
|
(8)
|
(6)
|
(1)
|
5
|
8
|
10
|
10
|
3
|
|
Income from Continuing Operations |
(2)
|
(2)
|
(2)
|
(3)
|
(6)
|
(7)
|
(8)
|
(8)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
10
|
28
|
42
|
51
|
46
|
42
|
37
|
40
|
28
|
15
|
(14)
|
(32)
|
(38)
|
(43)
|
(35)
|
|
Net Income (Common) |
(2)
N/A
|
(2)
-3%
|
(2)
-10%
|
(3)
-20%
|
(6)
-135%
|
(7)
-16%
|
(8)
-9%
|
(8)
-7%
|
(6)
+28%
|
(6)
-8%
|
(6)
-1%
|
(6)
+0%
|
(6)
-2%
|
(6)
+3%
|
(6)
+5%
|
10
N/A
|
28
+167%
|
42
+52%
|
51
+21%
|
46
-10%
|
42
-9%
|
37
-13%
|
40
+10%
|
28
-31%
|
15
-46%
|
(14)
N/A
|
(32)
-123%
|
(38)
-20%
|
(43)
-12%
|
(35)
+17%
|
|
EPS (Diluted) |
-0.19
N/A
|
-0.2
-5%
|
-0.21
-5%
|
-0.26
-24%
|
-0.5
-92%
|
-0.63
-26%
|
-0.61
+3%
|
-0.67
-10%
|
-0.47
+30%
|
-0.5
-6%
|
-0.39
+22%
|
-0.37
+5%
|
-0.36
+3%
|
-0.37
-3%
|
-0.25
+32%
|
0.35
N/A
|
0.94
+169%
|
1.52
+62%
|
1.71
+13%
|
1.56
-9%
|
1.41
-10%
|
1.23
-13%
|
1.16
-6%
|
0.86
-26%
|
0.47
-45%
|
-0.45
N/A
|
-1.06
-136%
|
-1.29
-22%
|
-1.45
-12%
|
-1.2
+17%
|